<p>(A) The Kaplan-Meier plot on the lower-right shows the survival impact of E2F2 gene expression in the multiple myeloma dataset GSE2658. Two expression groups are defined using the median E2F2 gene expression across all samples as the splitting value, and log-rank test is used to compute the p-value. Higher expression of E2F2 leads to high-risk (red) while lower expression leads to lower risk (blue).</p
Gene expression profiling can be used for predicting survival in multiple myeloma (MM) and identifyi...
<p><b>A.</b> Kaplan-Meier curves show differential survival of patients with predicted good (red) an...
<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low ...
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breas...
<p>(A) Visualization of differential gene expression for B-Cell Activation pathway members in normal...
Kaplan-Meier plots of the survival analysis of GC patient data: Kaplan-Meier plots of the survival a...
<p>The overall survival of GBM patients was used for the survival analysis. Expression values of a g...
Additional file 2: Figure S2. KaplanâMeier survival analysis for overall survival (OS) using diffe...
Gene expression profiling can be used for predicting survival in multiple myeloma (MM) and identifyi...
These high vs. low gene expression curves represent overall survival in breast cancer patients for e...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Multiple myeloma is an incurable blood cancer affecting more than 20,000 Americans each year. Sub-cl...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
<p>(A, B) Her2 expression, but not (C) Her2 status according to FDA/EMEA was associated with better ...
Gene expression profiling can be used for predicting survival in multiple myeloma (MM) and identifyi...
<p><b>A.</b> Kaplan-Meier curves show differential survival of patients with predicted good (red) an...
<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low ...
<p>Kaplan-Meier plots showing time of overall survival (OS) and relapse-free survival (RFS) of breas...
<p>(A) Visualization of differential gene expression for B-Cell Activation pathway members in normal...
Kaplan-Meier plots of the survival analysis of GC patient data: Kaplan-Meier plots of the survival a...
<p>The overall survival of GBM patients was used for the survival analysis. Expression values of a g...
Additional file 2: Figure S2. KaplanâMeier survival analysis for overall survival (OS) using diffe...
Gene expression profiling can be used for predicting survival in multiple myeloma (MM) and identifyi...
These high vs. low gene expression curves represent overall survival in breast cancer patients for e...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Multiple myeloma is an incurable blood cancer affecting more than 20,000 Americans each year. Sub-cl...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
Multiple myeloma (MM), a hematologic malignancy, is characterized by malignant plasma cells clonal p...
<p>(A, B) Her2 expression, but not (C) Her2 status according to FDA/EMEA was associated with better ...
Gene expression profiling can be used for predicting survival in multiple myeloma (MM) and identifyi...
<p><b>A.</b> Kaplan-Meier curves show differential survival of patients with predicted good (red) an...
<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low ...